Get the Stockscreener App
1.60
0.00%
0.00
After Hours:
1.68
0.08
+5.00%
Lava Therapeutics Nv Stock (LVTX) Forecast
The Lava Therapeutics Nv (LVTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.9504, representing a +84.40% increase from the current price of $1.60. The highest analyst price target is $2.8507, and the lowest is $3.0501.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LVTX Price Target
Average 4.2271
(+164.19% Upside)
Is Lava Therapeutics Nv (LVTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.75 | Neutral |
| STOCH(9,6) | 34.32 | Neutral |
| STOCHRSI(14) | 55.17 | Neutral |
| MACD(12,26) | -0.0567 | Sell |
| ADX(14) | 16.88 | Neutral |
| William %R | -67.44 | Neutral |
| CCI(14) | 11.18 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.5715
Buy
|
1.6053
Sell
|
| MA20 |
1.6883
Sell
|
1.6548
Sell
|
| MA50 |
1.7105
Sell
|
1.7181
Sell
|
| MA100 |
1.7798
Sell
|
1.8173
Sell
|
| MA200 |
2.1927
Sell
|
1.8699
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, LVTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on LVTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.75 indicates that LVTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.32 indicates that LVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 55.17 indicates that LVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.88 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 11.18 indicates that LVTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LVTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lava Therapeutics Nv financial reports and earnings history, Lava Therapeutics Nv (LVTX) stock could reach $10.06 by 2030, $37.72 by 2040 and $73.15 by 2050. See the projected annual prices until 2050 of the Lava Therapeutics Nv stock below:
- Lava Therapeutics Nv (LVTX) is expected to reach an average price of $35.92 in 2035, with a high prediction of $35.32 and a low estimate of $33.67. This indicates an $2,145% rise from the last recorded price of $1.60.
- Lava Therapeutics Nv (LVTX) stock is projected to chart a bullish course in 2040, with an average price target of $37.32, representing an $2,233% surge from its current level. The forecast ranges from a conservative $37.42 to a sky-high $37.72.
- Our analysts predict Lava Therapeutics Nv (LVTX) to jump 1,280% by 2045, soaring from $22.22 to an average price of $22.08, potentially reaching $23.23. While $22.22 is the low estimate, the potential upside is significant.
- Lava Therapeutics Nv (LVTX) stock is expected to climb by 2050, reaching an average of $72.81, a $4,451% jump from its current level. However, a wide range of estimates exists, with high and low targets of $73.15 and $72.92, respectively, highlighting the market's uncertainty.
Lava Therapeutics Nv Stock (LVTX) Year by Year Forecast
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2025
Lava Therapeutics Nv Stock (LVTX) is expected to reach an average price of $4.2271 in 2025, with a high prediction of $5.404 and a low estimate of $3.0501. This indicates an +164.19% rise from the last recorded price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.4607 | $3.0501 | $2.8507 | +116.30% |
| February, 2025 | $4.7882 | $3.3696 | $3.6182 | +199.26% |
| March, 2025 | $4.7856 | $4.5178 | $4.475 | +199.10% |
| April, 2025 | $3.8899 | $3.9199 | $4.3497 | +143.12% |
| May, 2025 | $4.9174 | $4.7705 | $4.5386 | +207.33% |
| June, 2025 | $4.6848 | $4.5328 | $4.4842 | +192.80% |
| July, 2025 | $4.7491 | $4.6317 | $4.6854 | +196.82% |
| August, 2025 | $5.7566 | $4.996 | $5.0966 | +259.78% |
| September, 2025 | $6.114 | $5.5003 | $5.404 | +282.12% |
| October, 2025 | $5.4683 | $5.0796 | $5.2083 | +241.77% |
| November, 2025 | $5.2957 | $5.4057 | $5.2189 | +230.98% |
| December, 2025 | $5.1501 | $5.3101 | $5.2107 | +221.88% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2026
The predicted value for Lava Therapeutics Nv (LVTX) in 2026 is set at an average of $3.1184. Estimates vary from a peak of $5.0838 to a trough of $1.153, indicating an +94.90% surge from the present price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8475 | $3.1206 | $5.0838 | +140.47% |
| February, 2026 | $2.8949 | $2.9949 | $3.4044 | +80.93% |
| March, 2026 | $1.2624 | $1.8524 | $2.1187 | -21.10% |
| April, 2026 | $3.3467 | $1.153 | $2.7468 | +109.17% |
| May, 2026 | $3.0741 | $3.0173 | $2.7704 | +92.13% |
| June, 2026 | $2.8116 | $2.8116 | $2.871 | +75.72% |
| July, 2026 | $4.0659 | $3.929 | $3.9022 | +154.12% |
| August, 2026 | $4.4133 | $4.3365 | $4.2296 | +175.83% |
| September, 2026 | $3.7576 | $3.9676 | $4.0208 | +134.85% |
| October, 2026 | $2.7651 | $3.535 | $3.5945 | +72.82% |
| November, 2026 | $3.1225 | $3.1625 | $3.0157 | +95.16% |
| December, 2026 | $3.0068 | $3.0767 | $3.0494 | +87.93% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lava Therapeutics Nv (LVTX) is $5.7187, with a high forecast of $11.41 and a low forecast of $0.0287. This indicates an +257.42% increase from the last price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.0243 | $3.0137 | $2.9305 | +89.02% |
| February, 2027 | $2.753 | $2.8117 | $2.738 | +72.06% |
| March, 2027 | $2.846 | $2.856 | $2.8054 | +77.88% |
| April, 2027 | $2.5835 | $2.8235 | $2.7847 | +61.47% |
| May, 2027 | $2.2709 | $2.2909 | $2.3803 | +41.93% |
| June, 2027 | $1.7052 | $1.9352 | $2.1473 | +6.58% |
| July, 2027 | $1.6227 | $1.7127 | $1.7389 | +1.42% |
| August, 2027 | $1.0101 | $1.1951 | $1.4895 | -36.87% |
| September, 2027 | $0.8356 | $0.0344 | $3.443 | -47.78% |
| October, 2027 | $0.1081 | $0.0372 | $1.4487 | -93.24% |
| November, 2027 | $9.25 | $0.0287 | $7.24 | +478.12% |
| December, 2027 | $12.01 | $9.5512 | $11.41 | +650.54% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2028
In 2028, Lava Therapeutics Nv (LVTX) is projected to reach an average price of $14.10, with a high projection of $16.38 and a low estimate of $11.83. This indicates an +781.38% rise from the last price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.13 | $11.83 | $11.40 | +658.34% |
| February, 2028 | $11.99 | $12.06 | $12.03 | +649.27% |
| March, 2028 | $14.63 | $12.00 | $12.45 | +814.19% |
| April, 2028 | $16.20 | $16.57 | $16.38 | +912.62% |
| May, 2028 | $15.46 | $15.38 | $15.15 | +866.28% |
| June, 2028 | $13.85 | $15.21 | $15.15 | +765.34% |
| July, 2028 | $13.36 | $13.41 | $13.56 | +735.02% |
| August, 2028 | $13.25 | $13.46 | $13.18 | +728.06% |
| September, 2028 | $14.26 | $14.08 | $14.41 | +791.49% |
| October, 2028 | $13.68 | $14.35 | $14.07 | +754.92% |
| November, 2028 | $14.25 | $13.43 | $13.94 | +790.45% |
| December, 2028 | $13.48 | $14.12 | $13.80 | +742.64% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2029
The 2029 price forecast for Lava Therapeutics Nv Stock (LVTX) is $10.98 on average, with a high prediction of $13.95 and a low estimate of $8.0059. This represents an +586.02% increase from the previous price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.62 | $13.66 | $13.61 | +751.30% |
| February, 2029 | $13.46 | $13.75 | $13.40 | +741.29% |
| March, 2029 | $13.91 | $13.96 | $13.95 | +769.41% |
| April, 2029 | $13.63 | $13.88 | $13.80 | +751.59% |
| May, 2029 | $13.44 | $13.31 | $13.34 | +740.25% |
| June, 2029 | $13.11 | $13.16 | $13.19 | +719.31% |
| July, 2029 | $12.77 | $12.87 | $12.92 | +698.36% |
| August, 2029 | $10.72 | $10.61 | $12.63 | +570.15% |
| September, 2029 | $9.2873 | $9.6672 | $9.9999 | +480.46% |
| October, 2029 | $7.0759 | $8.0059 | $8.581 | +342.25% |
| November, 2029 | $9.5208 | $9.7808 | $9.4935 | +495.05% |
| December, 2029 | $9.2157 | $9.4357 | $9.352 | +475.98% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2030
Lava Therapeutics Nv Stock (LVTX) is expected to reach an average price of $8.0265 in 2030, with a high forecast of $10.18 and a low forecast of $5.8739. This signifies an +401.66% surge from the last price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.08 | $9.1332 | $10.06 | +530.27% |
| February, 2030 | $10.31 | $10.04 | $10.18 | +544.33% |
| March, 2030 | $9.8441 | $9.8741 | $10.07 | +515.26% |
| April, 2030 | $9.269 | $9.299 | $9.6878 | +479.31% |
| May, 2030 | $8.4576 | $8.6076 | $9.0127 | +428.60% |
| June, 2030 | $8.1125 | $8.2425 | $8.2213 | +407.03% |
| July, 2030 | $7.9211 | $7.8474 | $7.9199 | +395.07% |
| August, 2030 | $7.356 | $7.406 | $7.6248 | +359.75% |
| September, 2030 | $7.2409 | $7.2409 | $7.2297 | +352.55% |
| October, 2030 | $6.9895 | $7.0485 | $7.0946 | +336.84% |
| November, 2030 | $6.2244 | $6.3744 | $6.7882 | +289.02% |
| December, 2030 | $5.7793 | $5.8739 | $6.0981 | +261.20% |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):